ReviewThe oncologist2025

New tool in the toolbox: patient selection for zolbetuximab in advanced treatment-naïve gastric/gastroesophageal junction adenocarcinoma.

Udhayvir S Grewal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.